Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway

Acta Pharmacologica Sinica, Published online: 16 September 2020; doi:10.1038/s41401-020-00515-1Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway

Source: Acta Pharmacologica Sinica - September 15, 2020 Category: Drugs & Pharmacology Authors: Deng-qiu Xu Lei Zhao Si-jia Li Xiao-fei Huang Chun-jie Li Li-xin Sun Xi-hua Li Lu-yong Zhang Zhen-zhou Jiang Source Type: research